Position in APTOF
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$6,813
+$6,813 QoQ
Shares Held
4,206
0.0% QoQ
Ownership
0.165%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1
of 2 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in APTOF Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Gleason Group, Inc. holds $93,091 across 7 Biotechnology names. APTOF ranks #6 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACTU |
Actuate Therapeutics, Inc.
|
19,028 | $29,112 | |
| 2 | RNTX |
Rein Therapeutics, Inc.
|
22,389 | $23,284 | |
| 3 | MDXG |
Mimedx Group, Inc.
|
2,712 | $10,441 | |
| 4 | INCY |
Incyte Corp
|
81 | $9,182 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
16 | $7,947 | |
| 6 | APTOF |
Aptose Biosciences Inc.
This page
|
4,206 | $6,813 | |
| 7 | CUE |
Cue Biopharma, Inc.
|
200 | $6,312 |
All Filings in APTOF
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,813 | 4,206 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | — | 4,206 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | — | 4,206 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | — | 4,206 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | — | 4,206 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | — | 40 | Shares | Sole | 2025-04-11 | |
| No filing history on record for this holder in this stock. | ||||||